Verrumal cutaneous solution

Verrumal is a specialized pharmaceutical product used for the treatment of common warts and plantar warts. The brand was originally developed by Almirall, a leading pharmaceutical company founded in Spain that focuses on skin health. The specific packaging shown indicates it is distributed in the Slovak market by Egis Pharmaceuticals, a major regional player in Central and Eastern Europe.

Historically, the production of Verrumal is primarily centered in Germany, specifically at Almirall Hermal GmbH facilities in Reinbek. Ownership of the brand remains with Almirall S.A., headquartered in Barcelona, which is a global biopharmaceutical company listed on the Spanish Stock Exchange. The product combines the active ingredients fluorouracil and salicylic acid to treat dermatological conditions via a topical solution.